Generation of a novel mouse model for the inducible depletion of macrophages in vivo

Genesis

Volumn 51, Issue 1, 2013, Pages 41-49

  Gheryani, Nabeia ^a   Coffelt, Seth B ^a   Gartland, Alison ^a   Rumney, Robin M H ^a   Kiss Toth, Endre ^a   Lewis, Claire E ^a   Tozer, Gillian M ^a   Greaves, David R ^b   Dear, T Neil ^a,c   Miller, Gaynor ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

CD68; Doxycycline; DTA; RtTA

Indexed keywords

CD68 ANTIGEN; CYTOKINE; DIPHTHERIA TOXIN; DOXYCYCLINE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE; CELL COUNT; CELL FUNCTION; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; LIVER; MACROPHAGE; MACROPHAGE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BONE AND BONES; CYTOKINES; DIPHTHERIA TOXIN; DOXYCYCLINE; IMMUNOSUPPRESSION; LIPOPOLYSACCHARIDES; LIVER; MACROPHAGES; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; PEPTIDE FRAGMENTS; SPLEEN;

ANIMALIA;

EID: 84872607256     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.22343     Document Type: Article

References (30)

1. Brennan FM, McInnes IB. 2008. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 118: 3537-3545.
2. Brownlie RJ, Lawlor KE, Niederer HA, Cutler AJ, Xiang Z, Clatworthy MR, Floto RA, Greaves DR, Lyons PA, Smith KG. 2008. Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb. J Exp Med 205: 883-895.
3. Burnett SH, Kershen EJ, Zhang J, Zeng L, Straley SC, Kaplan AM, Cohen DA. 2004. Conditional macrophage ablation in transgenic mice expressing a FAS-based suicide gene. J Leukoc Biol 75: 612-623.
4. Coffelt SB, Hughes R, Lewis CE. 2009. Tumor-associated macrophages: Effectors of angiogenesis and tumor progression. Biochim Biophys Acta 1796: 11-18.
5. De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M, Naldini L. 2005. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8: 211-226.
6. DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N, Coussens LM. 2009. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16: 91-102.
7. Dipietro LA, Strieter RM. 2002. Macrophages in wound healing. In: Burke B, Lewis CE, editors. The macrophage, 2nd ed. Oxford, UK: Oxford University Press, 434-456.
8. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP. 2005. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115: 56-65.
9. Firestein GS, Zvaifler NJ. 1990. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 33: 768-773.
10. Gordon S, Taylor PR. 2005. Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964.
11. Goswami S, Sahai E, Wyckoff JB, Cammer M, Cox D, Pixley FJ, Stanley ER, Segall JE, Condeelis JS. 2005. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 65: 5278-5283.
12. Gough PJ, Gordon S, Greaves DR. 2001. The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo. Immunology 103: 351-361.
13. Gracie JA, Forsey RJ, Chan WL, Gilmour A, Leung BP, Greer MR, Kennedy K, Carter R, Wei XQ, Xu D, Field M, Foulis A, Liew FY, McInnes IB. 1999. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 104: 1393-1401.
14. Greaves DR, Gordon S. 2003. Macrophage-specific gene targeting in vivo. In: Gordon S, editor. The macrophage as therapeutic target. London, UK: Springer, 89-109.
15. Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, Charles K, Klemm F, Pukrop T, Binder C, Balkwill FR. 2005. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol 175: 1197-1205.
16. Lee P, Morley G, Huang Q, Fischer A, Seiler S, Horner JW, Factor S, Vaidya D, Jalife J, Fishman GI. 1998. Conditional lineage ablation to model human diseases. Proc Natl Acad Sci USA 95: 11371-11376.
17. Lees RL, Sabharwal VK, Heersche JN. 2001. Resorptive state and cell size influence intracellular pH regulation in rabbitosteoclasts cultured on collagen-hydroxyapatite films. Bone 28: 187-194.
18. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Xue XN, Pollard JW. 2006. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66: 11238-11246.
19. Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T. 2000. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 1: 376-382.
20. Moore KJ, Fabunmi RP, Andersson LP, Freeman MW. 1998. In vitro-differentiated embryonic stem cell macrophages: A model system for studying atherosclerosis-associated macrophage functions. Arterioscler Thromb Vasc Biol 18: 1647-1654.
21. Ojogun N, Kuang TY, Shao B, Greaves DR, Munford RS, Varley AW. 2009. Overproduction of acyloxyacyl hydrolase by macrophages and dendritic cells prevents prolonged reactions to bacterial lipopolysaccharide in vivo. J Infect Dis 200: 1685-1693.
22. Papadimitriou JM, Ashman RB. 1989. Macrophages: Current views on their differentiation, structure, and function. Ultrastruct Path 13: 343-372.
23. Pelegri C, Franch A, Castellote C, Castell M. 1995. Immunohistochemical changes in synovial tissue during the course of adjuvant arthritis. J Rheum 22: 124-132.
24. Pillai MM, Hayes B, Torok-Storb B. 2009. Inducible transgenes under the control of the hCD68 promoter identifies mouse macrophages with a distribution that differs from the F4/80 - and CSF-1R-expressing populations. Exp Hematol 37: 1387-1392.
25. Stanley ER, Berg KL, Einstein DB, Lee PS, Pixley FJ, Wang Y, Yeung YG. 1997. Biology and action of colony-stimulating factor-1. Mol Reprod Dev 46: 4-10.
26. Trebec DP, Chandra D, Gramoun A, Li K, Heersche JN, Manolson MF. 2007. Increased expression of activating factors in large osteoclasts could explain their excessive activity in osteolytic diseases. J Cell Biochem 101: 205-220.
27. van Reyk DM, Jessup W. 1999. The macrophage in atherosclerosis: Modulation of cell function by sterols. J Leuk Biol 66: 557-561.
28. Van Rooijen N, Sanders A. 1994. Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications. J Immunol Methods 174: 83-93.
29. Vats D, Mukundan L, Odegaard JI, Zhang L, Smith KL, Morel CR, Wagner RA, Greaves DR, Murray PJ, Chawla A. 2006. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab 4: 13-24.
30. Wehling M, Spencer MJ, Tidball JG. 2001. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 155: 123-131.